According to Eurocine Vaccines AB latest financial reports the cash on hand of 8X4 is $102.17K, an decrease of -92.67% to 2022. At the end of 2022 company had $1.39M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $102.17K | -92.67% |
2022 | $1.39M | 2.70% |
2021 | $1.36M | -56.59% |
2020 | $3.13M | 544.87% |
2019 | $485.09K | - |